Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUPPORTS: orBec for Acute GI GVHD
NCT00926575Phase 3Terminated
- Sponsor
- Soligenix
- Start
- Oct 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclomethasone dipropionate in acute gastrointestinal graft-versus-host disease (aGI-GVHD), sponsored by Soligenix. Started Oct 2009; status: terminated.
02
Drugs
beclomethasone dipropionate
03
Conditions
acute gastrointestinal graft-versus-host disease (aGI-GVHD)
Beyond the preview
Go deeper on NCT00926575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00926575.